Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: author's response

MeSH terms

• Administration, Intravenous
• Administration, Oral
• Amphotericin B* / administration & dosage
• Amphotericin B* / therapeutic use
• Antifungal Agents* / administration & dosage
• Antifungal Agents* / therapeutic use
• COVID-19* / complications
• Diabetes Complications
• Humans
• Mucormycosis* / drug therapy
• SARS-CoV-2
• Triazoles* / administration & dosage
• Triazoles* / therapeutic use